Blog
BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know
Black Diamond Therapeutics BDTX is building its equity story around one drug, silevertinib, a brain-penetrant, fourth-generation EGFR inhibitor being studied in EGFR–mutant non-small cell lung
Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?
Veracyte VCYT is well poised to grow in the upcoming quarters owing to its ongoing sales momentum of Afirma and Decipher Prostate tests. Meanwhile, operational headwinds from macroeconomic pressures
Can Ericsson's 5G Innovation Network in Canada Drive Future Growth?
Ericsson ERIC has partnered with the Government of Canada to launch the Advanced Wireless Communications Innovation Network (AWIN), a new 5G platform focused on strengthening the country’s defense
Is Molina Healthcare Worth Buying at a Premium 26.83X P/E Valuation?
Molina Healthcare, Inc. MOH is a multi-state managed care organization that provides healthcare services under Medicaid, Medicare and state insurance marketplaces. The company operates through four
Modine Q4 Earnings Beat Estimates on Data Center Demand
Modine Manufacturing Company MOD posted adjusted earnings of $1.71 per share for the fourth quarter of fiscal 2026, which increased 53% from the year-ago quarter and came above the Zacks Consensus
WTI Crude Lowest in Five Weeks
News this morning is keeping pre-market futures alight while sending spot oil prices down: Iran State TV is openly discussing a draft for a peace deal with the U.S. that would end the war begun in
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
Insulet Corporation PODD is leaning on Omnipod 5 momentum to open 2026 with a faster growth profile than most medical products peers. Demand across Type 1 diabetes and early Type 2 diabetes is the
META Rides on Solid Momentum in Ad Business: A Sign of More Upside?
Meta Platforms META is benefiting from solid momentum in its advertising business. In the first quarter of 2026, the company reported a 33% year-over-year increase in family of apps ad revenue
AXTI's AI-Driven Indium Phosphide Boom: Is Hypergrowth Sustainable?
AXT’s AXTI first-quarter 2026 results suggest the company is rapidly emerging as a critical supplier to the AI optical infrastructure buildout, but the key debate now is whether execution can keep
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
NeuroPace, Inc. NPCE is moving through a clean strategic reset in 2026. The company is exiting the DIXI Medical distribution business and leaning fully into its core responsive neurostimulation
Here's How Taiwan Semiconductor Is Scaling Up to Meet Surging AI Demand
One of the key growth catalysts for Taiwan Semiconductor Manufacturing Company TSM, popularly known as TSMC, is its aggressive expansion of advanced-node manufacturing capacity. TSMC has highlighted
Dynamic Tactical ETF (DYTA) Touches a New 52-Week High
For investors seeking momentum, the SGI Dynamic Tactical ETF DYTA is probably on the radar now. The fund just hit a 52-week high and jumped 16.3% from its 52-week low price of $26.96 per share.
But
Tech ETFs to Buy as Micron Technology Joins the $1 Trillion Club
In a historic milestone on May 26, 2026, Micron Technology’s MU market capitalization crossed the $1 trillion threshold, driven by an extraordinary 19.3% single-day stock rally that lifted shares to
The Asymmetric AI Winner: Cybersecurity ETFs Gaining From Cloud Buildout
As global enterprises pour trillions into decentralized cloud networks and custom artificial intelligence (AI) silicon, the digital attack surface has been expanding at an unprecedented rate
AutoZone Q3 Earnings Beat Estimates on Strong Sales Growth
AutoZone, Inc. AZO posted third-quarter fiscal 2026 (ended May 9, 2026) earnings per share of $38.07, topping the Zacks Consensus Estimate of $36.18 by 5.2%. Earnings per share rose 7.7% from $35.36
Here's Why Investors Should Add Expeditors Stock to Their Portfolio
Expeditors International of Washington, Inc. (EXPD) performed well in the past year and has the potential to sustain the momentum in the future. If you have not taken advantage of its share price
Is Colgate Too Dependent on Pricing Actions for Revenue Growth?
Colgate-Palmolive Company CL is striving for a balance between volume and pricing, rather than relying solely on price increases to drive revenues. In the first quarter of fiscal 2026, the company
Canadian Imperial Scheduled to Report Q2 Earnings: What's in Store?
Canadian Imperial Bank of Commerce CM is slated to report second-quarter fiscal 2026 (ended April 30) results on May 28, before market open. The company’s quarterly earnings are expected to have
NPCE Explains How NeuroPace's RNS System Makes Money
NeuroPace, Inc. NPCE is tightening its focus around one thing: the RNS System, a closed-loop implant built for drug-resistant epilepsy. The setup is designed to generate recurring procedure-driven
3 Growth Stocks From the P&C Insurance Space to Boost Your Portfolio
The Zacks Property and Casualty Insurance industry is placed within the top 29% of the 245 Zacks industries. It currently carries Zack Industry Rank #72. The insurers remain well-poised for growth
Seagate vs. NetApp: Which Data Management Stock is the Better Bet?
The explosion of AI, cloud computing and enterprise data analytics has transformed data infrastructure into one of the most evolving technology themes of today. Companies are generating, storing and
Are Options Traders Betting on a Big Move in Verisk Analytics Stock?
Investors in Verisk Analytics, Inc. VRSK need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 18, 2026 $140 Call had some of the highest




.jpg?locale=de)
